Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.

Breast Cancer Res · 2014 · PMC3978822 · PMID 24451109

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

57.5% for nonfailures), the difference in AR staining percentage did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.